至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting.

Eur J Pharm Biopharm. 2018-09; 
RanRui,WangHaofei,LiuYun,HuiYue,SunQi,SethArjun,WibowoDavid,ChenDong,ZhaoChun
Products/Services Used Details Operation
Peptide Synthesis … This strategy could pave the way for the liposome-based pharmaceutical applications. 2. Materials and methods. 2.1. Materials. TAT peptide with a terminated cysteine (Cys-TAT, CYGRKKRRQRRR, MW 1663) was synthesized by GenScript Corporation (Piscataway, NJ, USA) … Get A Quote

摘要

Precise engineering of nanoparticles with systematically varied properties (size, charge surface properties, targeting ligands, etc.) remains a challenge, limiting the effective optimization of nanoparticles for particular applications. Herein we report a single-step microfluidic combinatorial approach for producing a library of single and dual-ligand liposomes with systematically-varied properties including size, zeta potential, targeting ligand, ligand density, and ligand ratio. A targeting ligand folic acid and a cell penetrating peptide TAT were employed to achieve the optimal synergistic targeting effect. In 2D cell monolayer models, the single-ligand folic acid modified liposome didn't s... More

关键词

Cell penetrating peptides,Dual-ligand liposomes,Folic acid,Microfluidics,Synergistic effect,Tumor targe